Tymon-Rosario J, Bonazzoli E, Bellone S, Manzano A, et al. DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active
against uterine serous carcinomas in vitro and in vivo. Gynecol Oncol 2021 Aug 24. pii: S0090-8258(21)01313.
PMID: 34452746